{"title":"Chapter 3.3: Case Study – Real-World Application in Longitudinal Analysis","markdown":{"yaml":{"title":"Chapter 3.3: Case Study – Real-World Application in Longitudinal Analysis","format":"html"},"headingText":"Chapter 3.3","containsRefs":false,"markdown":"\n\n## Case Study: Real-World Longitudinal Causal Inference Using Targeted Learning\n\nThis chapter walks through a **complete applied example** of longitudinal causal inference using real-world data concepts.  \nThe goal is to help you translate the earlier theoretical chapters into a practical analysis workflow.\n\nWe use the motivating real-world question:\n\n> **What is the 3-year cardiovascular risk difference if all eligible patients initiating osteoporosis therapy remained on denosumab vs. zoledronic acid under full adherence?**\n\nAlthough we cannot use the proprietary data from the actual studies, this chapter recreates a *plausible longitudinal structure* and walks you through the entire pipeline:\n\n- Constructing the longitudinal dataset  \n- Defining the causal question, intervention, and estimand  \n- Identifying longitudinal confounders and censoring  \n- Using SuperLearner for nuisance function estimation  \n- Applying TMLE or LMTP for longitudinal causal effects  \n- Interpreting the results in a regulatory and clinical context  \n\nThis chapter integrates lessons from Chapter 1 (causal roadmap) and Chapter 2 (estimation).\n\n---\n\n# 1. The Clinical and Real-World Context\n\nOsteoporosis treatments such as **denosumab** and **zoledronic acid** are widely used in postmenopausal women.  \nObservational data registries show:\n\n- Frequent **treatment interruptions**  \n- **Switching** between agents  \n- **Loss to follow-up**  \n- Time-varying covariates (e.g., frailty, kidney function, fall risk)\n\nThese complexities make longitudinal causal inference necessary.\n\nA naive Cox model adjusting for baseline covariates would **fail** to address:\n\n- Time-varying confounding affected by prior treatment  \n- Informative censoring (patients at higher risk may discontinue)  \n- Treatment switching  \n- Differing follow-up time  \n- Positivity issues  \n\nWe instead use **Longitudinal TMLE** or **LMTP** to estimate causal effects under hypothetical longitudinal interventions.\n\n---\n\n# 2. The Longitudinal Data Structure\n\nAssume patient \\(i\\) is followed monthly for 36 months.\n\nThe canonical structure:\n\n\\[\nO_i = (W_i, A_{i0}, L_{i1}, A_{i1}, C_{i1}, L_{i2}, A_{i2}, C_{i2}, \\dots, Y_i)\n\\]\n\nWhere:\n\n- **W**: baseline covariates (age, CVD history, frailty)\n- **A_t**: treatment status at time \\(t\\) (1 = denosumab, 0 = zoledronic acid)\n- **L_t**: time-varying covariates (kidney function, fracture risk, comorbidities)\n- **C_t**: censoring/loss to follow-up (1 = censored)\n- **Y**: cardiovascular event by 36 months\n\nWe simulate a small example below.\n\n---\n\n# 3. Simulation of a Plausible Longitudinal Dataset\n\n```{r}\nlibrary(tidyverse)\n\nset.seed(2027)\nn <- 2000\nTmax <- 6   # six timepoints for illustration\n\n# Baseline\nW_age  <- rnorm(n, 75, 6)\nW_cvd  <- rbinom(n, 1, plogis(0.12 * (W_age - 70)))\n\n# Initial treatment\nA0 <- rbinom(n, 1, plogis(-1 + 0.1*(W_age - 70) + 1.4*W_cvd))\n\n# Containers\nL <- matrix(NA, n, Tmax)\nA <- matrix(NA, n, Tmax)\nC <- matrix(0, n, Tmax)\n\nA[,1] <- A0\n\n# Generate longitudinal covariates & treatment\nfor (t in 1:Tmax) {\n  # time-varying comorbidity\n  L[,t] <- rnorm(n, mean = 0.3*W_age + 1.2*W_cvd + 0.5*A[,max(1,t-1)], sd = 1)\n\n  # treatment switching\n  A[,t] <- rbinom(n, 1, plogis(-2 + 0.3*L[,t] + 0.8*A[,max(1,t-1)]))\n\n  # censoring\n  C[,t] <- rbinom(n, 1, plogis(-4 + 0.2*L[,t] + 0.4*A[,t]))\n}\n\n# Outcome depends on full history\nY <- rbinom(n, 1, plogis(-3 + 0.5*rowMeans(A) + 0.1*rowMeans(L)))\n\ndat_long <- tibble(\n  id = 1:n,\n  age = W_age,\n  cvd = W_cvd,\n  Y = Y\n)\n\n# Expand wide data into long format (illustrative)\nfor (t in 1:Tmax) {\n  dat_long[[paste0(\"L\",t)]] <- L[,t]\n  dat_long[[paste0(\"A\",t)]] <- A[,t]\n  dat_long[[paste0(\"C\",t)]] <- C[,t]\n}\n\nglimpse(dat_long)\n```\n\n---\n\n# 4. Defining the Longitudinal Causal Question\n\nOur target estimand:\n\n> **What is the 36-month cardiovascular event risk if everyone remained continuously on denosumab vs continuously on zoledronic acid?**\n\nThis is a **static treatment regime**:\n\n\\[\nd_1: A_t = 1 \\ \forall t  \n\\]\n\\[\nd_0: A_t = 0 \\ \forall t\n\\]\n\nEquivalent to a “perfect adherence” scenario.\n\nWe can also define:\n\n- **Dynamic regimes** (treatment depends on predicted fracture risk)\n- **Stochastic regimes** (shift interventions on treatment probabilities)\n\nBut for now we use static interventions.\n\n---\n\n# 5. Identification: Assumptions for Longitudinal Effects\n\nTo identify the causal effect using observed data, we require:\n\n- **Sequential exchangeability:**  \n  \\( Y^{\\bar a} \\perp A_t \\mid \\bar L_t, \\bar A_{t-1}, W \\)\n- **Sequential positivity:**  \n  Each treatment is possible at each time for every covariate history\n- **Consistency:**  \n  Observed outcomes correspond to the regime actually followed\n\nThese are the longitudinal analogues of the point-treatment assumptions.\n\n---\n\n# 6. Using LMTP for Longitudinal Interventions\n\nThe **lmtp** package is a modern tool for estimating longitudinal modified treatment policies (MTPs).  \nIt supports:\n\n- Static interventions  \n- Dynamic rules  \n- Stochastic shifts  \n- Censoring adjustments  \n\nHere we implement:\n\n```{r, eval=F}\n# Example skeleton \n library(lmtp)\n\nresult <- lmtp_tmle(\n  data = dat_long,\n  trt = paste0(\"A\", 1:Tmax),\n  outcome = \"Y\",\n  time = 1:Tmax,\n  shift = function(data, trt) { rep(1, length(trt)) },  # always-denosumab\n  learners_outcome = list(SL.glm, SL.ranger),\n  learners_trt = list(SL.glm, SL.ranger),\n  folds = 5\n)\n\nresult\n```\n\nThis gives a TMLE estimate of:\n\n- Risk under always-denosumab  \n- Risk under always-ZA  \n- Risk difference  \n- Confidence intervals  \n\n---\n\n# 7. Using Longitudinal TMLE (Manual Concept)\n\nLongitudinal TMLE proceeds:\n\n1. Start at final timepoint  \n2. Estimate Q-models backward in time  \n3. Estimate g-models for each treatment and censoring event  \n4. Apply sequential targeting  \n5. Compute counterfactual outcomes  \n\nThis is mathematically complex but **automated by LMTP** in most real applications.\n\n---\n\n# 8. Interpretation of Results\n\nAssume hypothetical results:\n\n| Regime | Estimated 36-mo risk |\n|--------|----------------------|\n| Always denosumab | 0.051 |\n| Always ZA        | 0.055 |\n\nATE (risk difference):\n\n```\n-0.004 (0.4 percentage points lower cardiovascular risk)\n```\n\nInterpretation:\n\n- The estimated cardiovascular risk difference between continuous denosumab vs continuous ZA is small.  \n- Both therapies appear similar in risk, consistent with findings in published RWE studies.  \n- Subgroup and sensitivity analyses may explore heterogeneity and robustness.\n\n---\n\n# 9. Sensitivity & Diagnostic Considerations\n\n### 9.1 Positivity\nCheck treatment probabilities at each timepoint.\n\n### 9.2 Extreme weights\nLMTP handles this better than IPTW, but diagnostics still matter.\n\n### 9.3 Truncation\nMay be needed for sparse treatment histories.\n\n### 9.4 Negative control outcomes\nUseful to diagnose unmeasured confounding.\n\n---\n\n# 10. Summary\n\nIn this chapter, you learned how to:\n\n- Build and structure longitudinal data  \n- Define static longitudinal interventions  \n- Apply LMTP/TMLE for longitudinal causal effects  \n- Interpret results in a real-world regulatory context  \n\nThis case study demonstrates how to use targeted learning methods to generate high-quality causal evidence from complex real-world data.\n\n```{r}\nsessionInfo()\n```\n","srcMarkdownNoYaml":"\n\n# Chapter 3.3  \n## Case Study: Real-World Longitudinal Causal Inference Using Targeted Learning\n\nThis chapter walks through a **complete applied example** of longitudinal causal inference using real-world data concepts.  \nThe goal is to help you translate the earlier theoretical chapters into a practical analysis workflow.\n\nWe use the motivating real-world question:\n\n> **What is the 3-year cardiovascular risk difference if all eligible patients initiating osteoporosis therapy remained on denosumab vs. zoledronic acid under full adherence?**\n\nAlthough we cannot use the proprietary data from the actual studies, this chapter recreates a *plausible longitudinal structure* and walks you through the entire pipeline:\n\n- Constructing the longitudinal dataset  \n- Defining the causal question, intervention, and estimand  \n- Identifying longitudinal confounders and censoring  \n- Using SuperLearner for nuisance function estimation  \n- Applying TMLE or LMTP for longitudinal causal effects  \n- Interpreting the results in a regulatory and clinical context  \n\nThis chapter integrates lessons from Chapter 1 (causal roadmap) and Chapter 2 (estimation).\n\n---\n\n# 1. The Clinical and Real-World Context\n\nOsteoporosis treatments such as **denosumab** and **zoledronic acid** are widely used in postmenopausal women.  \nObservational data registries show:\n\n- Frequent **treatment interruptions**  \n- **Switching** between agents  \n- **Loss to follow-up**  \n- Time-varying covariates (e.g., frailty, kidney function, fall risk)\n\nThese complexities make longitudinal causal inference necessary.\n\nA naive Cox model adjusting for baseline covariates would **fail** to address:\n\n- Time-varying confounding affected by prior treatment  \n- Informative censoring (patients at higher risk may discontinue)  \n- Treatment switching  \n- Differing follow-up time  \n- Positivity issues  \n\nWe instead use **Longitudinal TMLE** or **LMTP** to estimate causal effects under hypothetical longitudinal interventions.\n\n---\n\n# 2. The Longitudinal Data Structure\n\nAssume patient \\(i\\) is followed monthly for 36 months.\n\nThe canonical structure:\n\n\\[\nO_i = (W_i, A_{i0}, L_{i1}, A_{i1}, C_{i1}, L_{i2}, A_{i2}, C_{i2}, \\dots, Y_i)\n\\]\n\nWhere:\n\n- **W**: baseline covariates (age, CVD history, frailty)\n- **A_t**: treatment status at time \\(t\\) (1 = denosumab, 0 = zoledronic acid)\n- **L_t**: time-varying covariates (kidney function, fracture risk, comorbidities)\n- **C_t**: censoring/loss to follow-up (1 = censored)\n- **Y**: cardiovascular event by 36 months\n\nWe simulate a small example below.\n\n---\n\n# 3. Simulation of a Plausible Longitudinal Dataset\n\n```{r}\nlibrary(tidyverse)\n\nset.seed(2027)\nn <- 2000\nTmax <- 6   # six timepoints for illustration\n\n# Baseline\nW_age  <- rnorm(n, 75, 6)\nW_cvd  <- rbinom(n, 1, plogis(0.12 * (W_age - 70)))\n\n# Initial treatment\nA0 <- rbinom(n, 1, plogis(-1 + 0.1*(W_age - 70) + 1.4*W_cvd))\n\n# Containers\nL <- matrix(NA, n, Tmax)\nA <- matrix(NA, n, Tmax)\nC <- matrix(0, n, Tmax)\n\nA[,1] <- A0\n\n# Generate longitudinal covariates & treatment\nfor (t in 1:Tmax) {\n  # time-varying comorbidity\n  L[,t] <- rnorm(n, mean = 0.3*W_age + 1.2*W_cvd + 0.5*A[,max(1,t-1)], sd = 1)\n\n  # treatment switching\n  A[,t] <- rbinom(n, 1, plogis(-2 + 0.3*L[,t] + 0.8*A[,max(1,t-1)]))\n\n  # censoring\n  C[,t] <- rbinom(n, 1, plogis(-4 + 0.2*L[,t] + 0.4*A[,t]))\n}\n\n# Outcome depends on full history\nY <- rbinom(n, 1, plogis(-3 + 0.5*rowMeans(A) + 0.1*rowMeans(L)))\n\ndat_long <- tibble(\n  id = 1:n,\n  age = W_age,\n  cvd = W_cvd,\n  Y = Y\n)\n\n# Expand wide data into long format (illustrative)\nfor (t in 1:Tmax) {\n  dat_long[[paste0(\"L\",t)]] <- L[,t]\n  dat_long[[paste0(\"A\",t)]] <- A[,t]\n  dat_long[[paste0(\"C\",t)]] <- C[,t]\n}\n\nglimpse(dat_long)\n```\n\n---\n\n# 4. Defining the Longitudinal Causal Question\n\nOur target estimand:\n\n> **What is the 36-month cardiovascular event risk if everyone remained continuously on denosumab vs continuously on zoledronic acid?**\n\nThis is a **static treatment regime**:\n\n\\[\nd_1: A_t = 1 \\ \forall t  \n\\]\n\\[\nd_0: A_t = 0 \\ \forall t\n\\]\n\nEquivalent to a “perfect adherence” scenario.\n\nWe can also define:\n\n- **Dynamic regimes** (treatment depends on predicted fracture risk)\n- **Stochastic regimes** (shift interventions on treatment probabilities)\n\nBut for now we use static interventions.\n\n---\n\n# 5. Identification: Assumptions for Longitudinal Effects\n\nTo identify the causal effect using observed data, we require:\n\n- **Sequential exchangeability:**  \n  \\( Y^{\\bar a} \\perp A_t \\mid \\bar L_t, \\bar A_{t-1}, W \\)\n- **Sequential positivity:**  \n  Each treatment is possible at each time for every covariate history\n- **Consistency:**  \n  Observed outcomes correspond to the regime actually followed\n\nThese are the longitudinal analogues of the point-treatment assumptions.\n\n---\n\n# 6. Using LMTP for Longitudinal Interventions\n\nThe **lmtp** package is a modern tool for estimating longitudinal modified treatment policies (MTPs).  \nIt supports:\n\n- Static interventions  \n- Dynamic rules  \n- Stochastic shifts  \n- Censoring adjustments  \n\nHere we implement:\n\n```{r, eval=F}\n# Example skeleton \n library(lmtp)\n\nresult <- lmtp_tmle(\n  data = dat_long,\n  trt = paste0(\"A\", 1:Tmax),\n  outcome = \"Y\",\n  time = 1:Tmax,\n  shift = function(data, trt) { rep(1, length(trt)) },  # always-denosumab\n  learners_outcome = list(SL.glm, SL.ranger),\n  learners_trt = list(SL.glm, SL.ranger),\n  folds = 5\n)\n\nresult\n```\n\nThis gives a TMLE estimate of:\n\n- Risk under always-denosumab  \n- Risk under always-ZA  \n- Risk difference  \n- Confidence intervals  \n\n---\n\n# 7. Using Longitudinal TMLE (Manual Concept)\n\nLongitudinal TMLE proceeds:\n\n1. Start at final timepoint  \n2. Estimate Q-models backward in time  \n3. Estimate g-models for each treatment and censoring event  \n4. Apply sequential targeting  \n5. Compute counterfactual outcomes  \n\nThis is mathematically complex but **automated by LMTP** in most real applications.\n\n---\n\n# 8. Interpretation of Results\n\nAssume hypothetical results:\n\n| Regime | Estimated 36-mo risk |\n|--------|----------------------|\n| Always denosumab | 0.051 |\n| Always ZA        | 0.055 |\n\nATE (risk difference):\n\n```\n-0.004 (0.4 percentage points lower cardiovascular risk)\n```\n\nInterpretation:\n\n- The estimated cardiovascular risk difference between continuous denosumab vs continuous ZA is small.  \n- Both therapies appear similar in risk, consistent with findings in published RWE studies.  \n- Subgroup and sensitivity analyses may explore heterogeneity and robustness.\n\n---\n\n# 9. Sensitivity & Diagnostic Considerations\n\n### 9.1 Positivity\nCheck treatment probabilities at each timepoint.\n\n### 9.2 Extreme weights\nLMTP handles this better than IPTW, but diagnostics still matter.\n\n### 9.3 Truncation\nMay be needed for sparse treatment histories.\n\n### 9.4 Negative control outcomes\nUseful to diagnose unmeasured confounding.\n\n---\n\n# 10. Summary\n\nIn this chapter, you learned how to:\n\n- Build and structure longitudinal data  \n- Define static longitudinal interventions  \n- Apply LMTP/TMLE for longitudinal causal effects  \n- Interpret results in a real-world regulatory context  \n\nThis case study demonstrates how to use targeted learning methods to generate high-quality causal evidence from complex real-world data.\n\n```{r}\nsessionInfo()\n```\n"},"formats":{"html":{"identifier":{"display-name":"HTML","target-format":"html","base-format":"html"},"execute":{"fig-width":7,"fig-height":5,"fig-format":"retina","fig-dpi":96,"df-print":"default","error":false,"eval":true,"cache":null,"freeze":false,"echo":true,"output":true,"warning":true,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"knitr"},"render":{"keep-tex":false,"keep-typ":false,"keep-source":false,"keep-hidden":false,"prefer-html":false,"output-divs":true,"output-ext":"html","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":true,"code-overflow":"scroll","code-link":false,"code-line-numbers":false,"code-tools":false,"tbl-colwidths":"auto","merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":false,"self-contained-math":false,"format-resources":[],"notebook-links":true},"pandoc":{"standalone":true,"wrap":"none","default-image-extension":"png","to":"html","toc":true,"output-file":"03-03-longitudinal-case-study.html"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","appendix-view-license":"View License","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words","listing-page-filter":"Filter","draft":"Draft"},"metadata":{"lang":"en","fig-responsive":true,"quarto-version":"1.6.42","theme":"cosmo","smooth-scroll":true,"title":"Chapter 3.3: Case Study – Real-World Application in Longitudinal Analysis","sidebar":{"style":"docked","search":true,"contents":[{"text":"Overview","href":"index.qmd"},{"section":"Advanced topics","contents":[{"text":"1.1 Regression vs Causal Inference","href":"01-01-regression-vs-causal.qmd"},{"text":"1.2 The Causal Roadmap in detail","href":"01-02-causal-roadmap.qmd"},{"text":"1.3 Identification and Estimands","href":"01-03-identification-estimands.qmd"},{"text":"2.1 G-computation","href":"02-01-gcomputation.qmd"},{"text":"2.2 Inverse Probability of Treatment Weighting (IPTW)","href":"02-02-iptw.qmd"},{"text":"2.3 Doubly Robust Estimation and Targeted Maximum Likelihood Estimation (TMLE)","href":"02-03-doubly-robust-tmle.qmd"},{"text":"2.4 Super Learner","href":"02-04-superlearner.qmd"},{"text":"3.3 Longitudinal Case Study","href":"03-03-longitudinal-case-study.qmd"},{"text":"3.4 Effect Modification","href":"03-04-effect-modification.qmd"},{"text":"3.5 Advanced Diagnostics","href":"03-05-advanced-diagnostics.qmd"},{"text":"3.6 RWD meets RCT: Hybrid Designs","href":"03-06-rwd-meets-rct-hybrid-designs.qmd"},{"text":"3.7 Longitudinal Time-Dependent Confounding","href":"03-07-longitudinal-td-confounding.qmd"},{"text":"3.8 TMLE in the Clean Room Design","href":"03-08-tmle-clean-room.qmd"},{"text":"Covariate Adjustment IN RCTs using TMLE","href":"chapter_covariate_adjustment_tmle.qmd"},{"text":"Common Pitfalls in Causal Inference","href":"common-pitfalls.qmd"}]}]}},"extensions":{"book":{"multiFile":true}}}},"projectFormats":["html"]}